Abstract
IHE has published a new comparator report on the cost of cancer and access to cancer medicines. The report is a condensed version of the previously published report, Comparator report on patient access to cancer medicines in Europe revisited (IHE Report 2016:4) and focusing on the UK.
The report reveals similar trends in the UK as in the rest of Europe: incidence of cancer is increasing, as is mortality in absolute terms but once demographic factors is accounted for mortality has decreased due to increased survival. However, compared to countries with similar economic status the UK lags behind.
The report reveals similar trends in the UK as in the rest of Europe: incidence of cancer is increasing, as is mortality in absolute terms but once demographic factors is accounted for mortality has decreased due to increased survival. However, compared to countries with similar economic status the UK lags behind.
| Original language | English |
|---|---|
| Number of pages | 51 |
| Publication status | Published - 2017 |
Publication series
| Name | IHE report |
|---|---|
| Publisher | IHE, Institutet för hälso- och sjukvårdsekonomi |
| No. | 2017:1 |
| ISSN (Electronic) | 1651-8187 |
Subject classification (UKÄ)
- Health Care Service and Management, Health Policy and Services and Health Economy
- Cancer and Oncology
